Dangerous Ideas In Drug Development podcast

Small molecule protein inhibition with Interdict Bio

0:00
29:48
15 Sekunden vorwärts
15 Sekunden vorwärts

In today's episode we are joined by Dr Lawrence Hamann from Interdict Bio! We hear about bioavailable small molecule drugs that can inhibit ribosomal protein synthesis in MYC-dependent cancers. We also learn some tips for people looking to get into a drug development career!

Weitere Episoden von „Dangerous Ideas In Drug Development“